Technologies for molecular diagnostics are delivering new tools to the clinical community for faster and more accurate decision making. Learning what the demands of the community are, where the unmet medical need is, and how the assays can best perform, are critical questions to be asking.
February 19-23, 2012
San Francisco, CA
Join Rina Wolf, Vice President of Commercialization Strategies, Consulting & Industry Affairs, XIFIN Inc., along with William Cook, M.B.A., Principal, Strategy and Business Development, Clinical Diagnostics, WECA and Patrick F. Terry, Principal, Pricing & Market Access Practice, Scientia Advisors for "Roadmap for Accelerating Commercialization of Molecular Diagnostics."
This short course is focused on development of molecular diagnostics as they make their way from biomarker discovery and initial proof of clinical performance through to commercial launch, partnership delivery and market development. The course will emphasize identification of critical hurdles that when addressed early, can materially accelerate progress. Vital areas to be covered include product pricing, reimbursement strategies, regulatory pathway decisions, provider engagement and key opinion leader development.
Examples and case studies of molecular diagnostic companies in will be shared to illustrate a real world roadmap including:
-Rationale for reimbursement – understanding coverage
-Regulatory clearance and navigating claims language and timing
-Maximizing clinical study results while addressing evolving evidence demands
The short course will take place on February 20 from 1:00-4:00pm.
Molecular Med Tri-Con is the key conference for molecular diagnostics showcasing technologies and criteria for success such as market access and payment. It will encompass payers and reimbursement, emerging markets, comparative effectiveness, and benefits to clinical trial management and therapy selection for patients. In its ninth year, this meeting will present the dynamic factors shaping the industry, and the enormous growth opportunities that exist.
Already going? Be sure to schedule time to connect with Rina onsite, by filling out the form on the right.
Interested in Going? Register today for the conference and short course!
Watch Highlights Video below
Opportunity to connect with XIFIN’s Rina Wolf
at Molecular Med Tri-Con 2012
Attend Rina’s Short Course on Accelerating Commercialization, or Schedule a Meeting
REQUEST A MEETING WITH RINA TODAY!
SHARE WITH
YOUR PEERS
Main Navigation: